Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2020
Share-based Payment Arrangement [Abstract]  
Schedule of Share-based payment award, Equity instruments Other than Options, Valuation Assumptions [Table Text Block]
The following table summarizes the key assumptions and related information used to determine the fair value of the liability awards as of September 30, 2020:
 
Restricted stock units
 
Performance stock units
Number of simulations
10,000,000
 
10,000,000
Expected stock volatility
113.8%
 
118.5%
Dividend yield
—%
 
—%
Risk-free interest rate
0.2%
 
0.2%

Schedule of Nonvested Performance-based Units Activity [Table Text Block]
The following table provides information about performance stock units outstanding during the nine months ended September 30, 2020.
 
Awards
 
Weighted Average Grant-Date Fair Value
Unvested balance as of December 31, 2019
872,672

 
$
13.44

Vested

 

Granted

 

Canceled
(193,391
)
 
21.53

Forfeited

 

Unvested balance as of September 30, 2020
679,281

 
11.13


Schedule of Stock-based Compensation Expense
The following table summarizes stock-based compensation expense recognized for the periods presented:
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
(in thousands)
2020
 
2019
 
2020
 
2019
Equity Awards
 
 
 
 
 
 
 
Restricted stock awards
$
3,864

 
$
4,569

 
$
11,605

 
$
11,159

Stock option awards
399

 
2,557

 
1,674

 
7,766

Performance stock units
653

 
918

 
2,659

 
2,360

Other stock-based compensation expense(1)
112

 
66

 
226

 
66

Total stock-based compensation - equity awards
5,028

 
8,110

 
16,164

 
21,351

Liability Awards
 
 
 
 
 
 
 
Restricted stock units
290

 

 
290

 

Performance stock units
197

 

 
197

 

Total stock-based compensation - liability awards
487

 

 
487

 

Total stock-based compensation expense
$
5,515

 
$
8,110

 
$
16,651

 
$
21,351

 
(1)  
Includes expenses related to the Company’s Employee Stock Purchase Plan (the “ESPP”). In May 2019, an aggregate of 2,000,000 shares were authorized by stockholders for issuance under the ESPP, which became effective on July 1, 2019. As of September 30, 2020, the Company had 1,837,381 shares of Class A Common Stock available for future issuance.
Schedule of Restricted Stock Activity
The following table provides information about restricted stock activity during the nine months ended September 30, 2020:
 
Awards
 
Weighted Average Grant-Date Fair Value
Unvested balance as of December 31, 2019
4,838,996

 
$
8.51

Granted
9,657,211

 
1.10

Vested
(1,847,059
)
 
8.69

Forfeited
(861,992
)
 
5.79

Unvested balance as of September 30, 2020
11,787,156

 
2.45


Summary of Stock Option Valuation Inputs
The following table summarizes the assumptions and related information used to determine the grant-date fair value of stock option awards for the periods presented:

Nine Months Ended September 30,

2020

2019
Weighted average grant-date fair value per share
$
1.16


$
4.47

Expected term (in years)
6


6

Expected stock volatility
86
%

46
%
Dividend yield
%

%
Risk-free interest rate
1.0
%

2.3
%

Summary of Stock Option Activity
The following table provides information about stock option awards outstanding during the nine months ended September 30, 2020:
 
Options
 
Weighted Average Exercise Price
 
Weighted Average Remaining Term
(in years)
 
Aggregate Intrinsic Value
(in thousands)
Outstanding as of December 31, 2019
4,764,167

 
$
15.99

 
 
 
 
Granted
124,000

 
2.13

 
 
 
 
Exercised
(366
)
 
0.25

 
 
 
$

Forfeited
(129,757
)
 
13.15

 
 
 
 
Expired
(2,325,391
)
 
16.37

 
 
 
 
Outstanding as of September 30, 2020
2,432,653

 
15.07

 
6.6
 
$
22

Exercisable as of September 30, 2020
1,955,295

 
15.78

 
6.2
 
$